BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 2, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 6, 2022
View Archived Issues
miR-34a induction is an approach against liver metastasis
Read More
HSP60 as biomarker of chemotherapeutic response in colorectal cancer
Read More
Shanghai Visonpharma patents agents for treating hepatitis B virus infections
Read More
New EGFR inhibitors identified at PharmaBlock Sciences
Read More
Jiangsu Hansoh Pharmaceutical Group, Shanghai Hansoh Biomedical patent CD73 inhibitors
Read More
Beijing Tide Pharmaceutical divulges SOS1/GTPase KRAS interaction inhibitors
Read More
New TYK2 inhibitors discovered at Jiangsu Chia Tai Tianqing Pharmaceutical Group
Read More
Identification of SCUBE3 as a novel therapeutic target in HCC
Read More
Blockade of DNMT1/UHRF1 complex may be an approach for NAFLD
Read More
Walden Biosciences enters research collaboration with University of Michigan on suPAR genetics
Read More
Novel Alzheimer's disease model lacking interaction between FKBP51 and HSP90 generated
Read More
Novel dual RAGE/SERT inhibitor shows promise as treatment of AD with comorbid depression
Read More
Bioprinted hepatocyte implants show potential long-term viability in vivo
Read More
Approved ALK inhibitors may provide pain relief
Read More
Postmortem brain study gives clues to long COVID
Read More
